Product
SHR7280
Aliases
SHR7280 tablets
5 clinical trials
7 indications
Indication
Uterine Fibroids With MenorrhagiaIndication
EndometriosisIndication
Uterine FibroidsIndication
Hormone-sensitive Prostate CancerIndication
Assisted ReproductionIndication
Prostate CancerClinical trial
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Phase II/III Clinical Study to Explore the Optimal Therapeutic Dose of SHR7280 Tablets and the Efficacy and Safety of SHR7280 Tablets in Subjects With Menorrhagia for Uterine FibroidsStatus: Recruiting, Estimated PCD: 2026-06-01
Clinical trial
A Multicentre, Open-label, ph2 Clinical Study to Investigate the Efficacy, Safety, and Tolerance of Different Doses of Oral SHR7280 Tablets in Controlled Ovarian Hyperstimulation for Chinese Female Subjects Undergoing Assisted Reproductive Technology (ART)Status: Completed, Estimated PCD: 2023-08-03
Clinical trial
Clinical Studies Evaluating the Relative Bioavailability of SHR7280 Dry Suspension and Tablets (Single-center, Randomized, Open-label, Crossover)Status: Completed, Estimated PCD: 2023-06-09
Clinical trial
A Phase I/II, Randomized, Double-Blind, Placebo-Controlled, Multiple-Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics ,Pharmacodynamics and Efficacy of SHR7280 Tablets in Premenopausal Subjects With Endometriosis.Status: , Estimated PCD: 2024-01-30
Clinical trial
An Open-Label, Multicenter, Dose Escalation And Expansion Study Of SHR7280 In Subjects With Hormone Sensitive Prostate CancerStatus: Completed, Estimated PCD: 2023-05-24